Resources
Act | West FY 23 Semi-Annual Report: April 2023 - September 2023
This report outlines the key achievements and challenges in the last six months of the fifth year of program implementation, spanning the period April 2023 - September 2023.
Act | West FY 23 Semi-Annual Report: October 2022 - March 2023
This report outlines the key achievements and challenges in the first six months of the fifth year of program implementation, spanning the period October 2022 - March 2023.
Act | West FY 22 Semi-Annual Report: April 2022 - September 2022
This report outlines the key achievements and challenges in the last six months of the fourth year of program implementation, spanning the period April 1, 2022 - September 31, 2022.
Act | West FY 22 Semi Annual Report: October 2021 - March 2022
This report outlines the key achievements and challenges in the first six months of the fourth year of program implementation, spanning the period October 1, 2021–March 31, 2022.
Act | West FY 21 Semi Annual Report: April 2021 - September 2021
This report outlines the key achievements and challenges in the last six months of the third year of program implementation, spanning the period April 1, 2021–September 30, 2021.
Severe Adverse Event Webinar
Adverse events (AEs) particularly severe adverse events (SAEs) during and following mass drug administration have a serious effect not only on the people who are affected directly, but also on the viability of the MOH’s national NTD control program.
FY20 Semi-Annual Report: April 2020—September 2020
The United States Agency for International Development (USAID) granted funding to FHI 360 for the implementation of Act to End Neglected Tropical Disease West (Act | West) program from July 19, 2018–July 18, 2023. The program is part of the global effort to eliminate neglected tropical diseases (NTDs). It particularly aims to eliminate lymphatic filariasis (LF), trachoma, and onchocerciasis (OV) (in certain countries) and control schistosomiasis (SCH) and soil-transmitted helminthiasis (STH) in 11 endemic West African countries—including Burkina Faso, Benin, Cameroon, Guinea, Ghana, Côte D’Ivoire, Mali, Niger, Senegal, Sierra Leone, and Togo. It also supports achievement of sustainable service delivery, with growing ownership of national governments in the elimination and/or control of NTDs. This report outlines the key achievements and challenges in the first six months of the second year of program implementation, spanning the period April 1, 2020–September 30, 2020.
Trachoma Surveys: Practical Approaches to Implementing WHO Guidance for Neglected Tropical Disease (NTD) Programs in the Context of COVID-19
Trachoma baseline surveys, trachoma impact surveys, trachoma surveillance surveys, and trichiasis-only surveys are key disease-specific assessments of trachoma elimination programs, used to start mass drug administration (MDA), monitor progress, decide when to stop MDA, and inform attainment of elimination of trachoma as a public health problem.
FY20 Semi-Annual Report: October 2019—March 2020
This report outlines the key achievements and challenges in the first six months of the second year of implementation of USAID's Act to End NTDs | West Program, spanning the period October 1, 2019–March 31, 2020.
Practical Approaches to Implementing WHO Guidance for Neglected Tropical Disease (NTD) Programs in the Context of COVID-19: Lymphatic Filariasis (LF) Surveys
This resource document complements the World Health Organization’s (WHO’s) guidance for NTD programs released on July 27, 2020.